Navigation Links
Gateway Analytical to Present Latest Research at the Drug Delivery to the Lungs Conference in Edinburg, Scotland
Date:12/16/2013

PITTSBURGH, Dec. 16, 2013 /PRNewswire-iReach/ -- Gateway Analytical will present a scientific poster discussing the application of Raman Chemical Imaging for testing particles in inhalable pharmaceuticals at this month's Drug Delivery to the Lungs 24 (DDL 24) Conference on December 12, 2013. This annual meeting serves as Europe's premier conference dedicated to pulmonary and nasal drug delivery and serves as an opportunity to learn the latest research and technologies being used and network with peers as well as other professionals from the pharmaceutical industry.

Oksana Olkhovyk, PhD will be presented to discuss Raman-based Analysis of Dispersed versus Aggregated Drug Particles in MDI Formulations for Chemically-Specific Sizing and Polymorphic Purity Assessment, and will discuss the results of using Raman Chemical Imaging (RCI) to investigate the Active Pharmaceutical Ingredients (API) particle size distribution (PSD) and degree of drug particle aggregation in a commercial MDI. Dr Olkhovyk will discuss the benefits of using Raman Chemical Imaging as a powerful analytical tool for differentiating particles by their chemical make-up to provide means to evaluate degree of drug-specific aggregates, which is especially effective in analysis of combination inhalation products.    

In addition to the scientific poster presentation at the conference, Gateway Analytical will host a VIP event at the Scotch Whisky Experience to meet with DDL 24 attendees and further discuss the company's experience in advanced analytical testing services for a wide range of pharmaceutical drug product types. During this cocktail reception, guests will be treated to an interactive tour of the distillery and tastings of authentic Scotch Malt Whisky.

"We are very excited to display our data at the DDL24 conference and present our findings to the pharmaceutical scientists and attendees at this conference," said Dr Olkhovyk, Senior Scientist at Gateway Analytical. "Our data discusses the benefits of using Raman Chemical Imaging (RCI) for chemically-specific testing – which is extremely important in the development of inhalation drugs."

RCI analysis aids in understanding dispersion of the drug particles and inhalation product aerosolization performance without time-consuming impaction analysis testing. With the recent release of the FDA Draft Guidance on Fluticasone Propionate and Salmeterol Xinafoate, our services can help to guide pharmaceutical customers through touch regulatory waters as they develop these types of DPI products and establish their bioequivalence."

Gateway Analytical is a full service FDA registered and inspected laboratory with specialized expertise in state-of-the-art techniques for chemically specific particle sizing and particulate contamination identification. The lab's accreditations include cGMP-compliant, ISO 9001:2008, 21 CFR parts 210 & 211, 21 CFR part 820, and ICH Q7.  By utilizing techniques such as optical and polarized light microscopy, Raman and FTIR spectroscopy, SEM/EDS and Raman, visible fluorescence and NIR chemical imaging, Gateway Analytical's scientists are able to offer unique forensic-based-testing methods to quickly address pharmaceutical issues such as identifying when and where foreign particulate matter enter a manufacturing process, pinpointing the root cause of product failures or investigating the source of product stains or discoloration.

For more information on Gateway Analytical's pharmaceutical forensic and investigation services, contact Tracey Safran, Senior Account Manager, at safrant@gatewayanalytical.com.

About Gateway Analytical

Based in Gibsonia, Pa., Gateway Analytical, LLC partners with companies in need of high-quality laboratory analysis that do not have the time, resources or capabilities for specialized, comprehensive testing. Through conventional and innovative testing methods, the company provides expert laboratory services and analytical solutions for the pharmaceutical, forensic and materials science industries.

Gateway Analytical is a subsidiary of ChemImage Corporation, a leader in chemical imaging technology and instrumentation.

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Media Contact: Tifanie Tiberio, ChemImage Corp., 4122417335, tiberiot@chemimage.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ChemImage Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Labome: The Gateway to the Perfect Antibody -- Labome Antibody Review Database Has Now Reached 10,000 Peer-Reviewed Formal Publications
2. Jeffrey Toobin Joins Gateway Public Schools for the 2013 Matters of the Mind Luncheon
3. Pittcon Recognizes Outstanding Achievements in Analytical Chemistry and Applied Spectroscopy
4. NSF International Acquires Brazil’s Bioensaios Analysis and Environmental Consultancy Ltd., a Leading Analytical Laboratory
5. HerbalGram Article Details Procedures for Choosing a Contract Analytical Lab for Dietary Ingredients
6. Renowned Lab Compliance Expert Ludwig Huber to Conduct ComplianceOnline Seminar on Analytical Instrument Qualification and System Validation
7. Process Analytical Technology/Quality by Design – Keeping An Eye on Your Quality, New Life Science Webinar Hosted by Xtalks
8. Biotrial Bioanalytical Services (BBS) Proves Top-Quality Performance by Successfully Passing Another FDA Inspection
9. Process Analytical Technology: The Future of Pharmaceutical Manufacturing is Now
10. SF Analytical Laboratories Approved for ISO 17025 Accreditation by ACLASS
11. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... August 13, 2019 , ... INDIGO Biosciences, Inc. ... solutions, announced the appointment of Mark McLoughlin to the Company’s Board of Directors. ... McLoughlin will lend his healthcare expertise and extensive background in laboratory and scientific ...
(Date:8/7/2019)... ... ... Locus Agricultural Solutions (Locus AG) reports record levels of carbon sequestered in ... ® , which is pulling up to 121% more carbon into the soil than ... from the treatment of almonds, cherries, turf/sod, grapes and citrus across the U.S., as ...
(Date:8/6/2019)... ... August 05, 2019 , ... Advanced Clinical, a ... a distinguished leader by PharmaVOICE magazine, earning him a prestigious spot on the ... July/August special issue. , As the executive vice president of business development and ...
(Date:7/30/2019)... ... July 30, 2019 , ... The summer ... cooking events company. Not only has the company already hosted many of its ... Cooking Parties to its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare ...
Breaking Biology Technology:
(Date:8/15/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... dedicated to building 100 companies over the next 10 years to address the urgent ... Deep Science Ventures was founded to create a better method for launching science companies; ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in ... learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, ... disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple ...
(Date:8/9/2019)... ... August 09, 2019 , ... With a demand in ... and more patients will visit urgent care centers (UCC) in the coming years, according ... report, The Market for Urgent Care Centers , is a detailed look at ...
Breaking Biology News(10 mins):